DASERGIN Film-coated tablet Ref.[50435] Active ingredients: Desloratadine

Source: Health Products Regulatory Authority (IE)  Revision Year: 2020  Publisher: HCS bvba, H.Kennisstraat 53, Edegem 2650, Belgium

Product name and form

Dasergin 5 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet (tablet)

Light blue, round, film-coated tablets with beveled edges (diameter: 6.5 mm, thickness: 2.3–3.5 mm).

Qualitative and quantitative composition

Each film-coated tablet contains 5 mg desloratadine.

Excipient with known effect: Each film-coated tablet contains 16.15 mg lactose (as monohydrate) and 0.201 mg (0.00875 mmol) sodium.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Desloratadine

Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-receptor antagonist activity. After oral administration, desloratadine selectively blocks peripheral histamine Η1-receptors because the substance is excluded from entry to the central nervous system.

List of Excipients

Tablet core:

Microcrystalline cellulose
Hypromellose
Hydrochloric acid (for pH-adjustment)
Sodium hydroxide (for pH-adjustment)
Maize starch
Lactose monohydrate
Talc

Film coating:

Hypromellose
Macrogol 400
Lactose monohydrate
Titanium dioxide (E171)
Indigo carmine (E132)

Pack sizes and marketing

Blister (OPA/Alu/PVC//Alu): 10, 30 or 100 film-coated tablets, in a box.

Not all pack sizes may be marketed.

Marketing authorization holder

HCS bvba, H.Kennisstraat 53, Edegem 2650, Belgium

Marketing authorization dates and numbers

PA2096/006/001

Date of first authorisation: 6th July 2018

Drugs

Drug Countries
DASERGIN Estonia, Ireland, Poland, Romania

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.